In WSU-DLCL2 xenograft bearing mice, tumor growth inhibition (TGI) was achieved at all EPZ-6438 doses and schedules employed, and was better than CHOP alone (Fig. 5A). This evidence concerns the gene DDIT3 and neoplasm.